Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
43%
OVERLAP
BY WEIGHT
13
# OF OVERLAPPING
HOLDINGS
FTXH
51
HOLDINGS
26%
ALSO IN MEDX
MEDX
27
HOLDINGS
48%
ALSO IN FTXH
SECTOR DRIFT (FTXH minus MEDX)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FTXH |
Weight in MEDX |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 7.9% | 18.5% | 7.9% |
|
ABBVIE INC | 7.2% | 8.5% | 7.2% |
|
JOHNSON & JOHNSON | 6.9% | 5.4% | 5.4% |
|
BRISTOL-MYERS SQUIBB CO | 6.7% | 4.7% | 4.7% |
|
MERCK & CO. INC. | 7.2% | 4.0% | 4.0% |
FTXH Overweight Relative to MEDX
|
VIATRIS, INC. | 3.6% |
|
VERTEX PHARMACEUTICALS INC | 3.3% |
|
CARDINAL HEALTH INC | 3.3% |
|
MERCK & CO. INC. | 3.2% |
|
GILEAD SCIENCES INC | 3.2% |
|
UNITED THERAPEUTICS CORP | 3.0% |
 |
JAZZ PHARMACEUTICALS PLC | 2.7% |
|
INCYTE CORP | 2.3% |
|
ZOETIS INC | 2.2% |
|
BRISTOL-MYERS SQUIBB CO | 2.1% |
FTXH Underweight Relative to MEDX
|
ELI LILLY & CO | -10.6% |
 |
NOVARTIS AG-ADR | -7.0% |
 |
ASTRAZENECA PLC | -5.2% |
|
IONIS PHARMACEUTICALS, INC. | -4.1% |
|
ALKERMES PLC | -3.6% |
|
ALNYLAM PHARMACEUTICALS INC | -3.2% |
|
GLAXOSMITHKLINE PLC-SPON ADR | -2.8% |
|
CRISPR THERAPEUTICS AG | -2.7% |
|
BEAM THERAPEUTICS, INC. | -1.4% |
|
ABBVIE INC | -1.3% |